<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01089985</url>
  </required_header>
  <id_info>
    <org_study_id>R724/08/2010</org_study_id>
    <nct_id>NCT01089985</nct_id>
  </id_info>
  <brief_title>Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye</brief_title>
  <official_title>Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore National Eye Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Singapore National Eye Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the efficacy and safety of autologous serum eye drops
      in people with recalcitrant dry eye.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A group of selected dry eye patients from the Singapore National Eye Centre who have
      exhausted the usual treatment options (lubricants, topical immunosuppressive and punctal
      occlusion) and not keen for tarsorrhaphy will be recruited. After informed consent, they will
      undergo plasmapheresis and start on daily autologous serum eyedrops for a period of 4 months.
      Clinical monitoring for standard dry eye parameters such as punctate corneal keratitis,
      Schirmers testing, tear break up time as well as severity and frequency of dry eye symptoms
      will be conducted. Tear inflammatory proteins captured on Schirmers paper pre and post
      treatment will be analysed as well.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Staining</measure>
    <time_frame>4 months</time_frame>
    <description>Grading of punctate corneal staining in the worse eye (second visit relative to first visit)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms</measure>
    <time_frame>4 months</time_frame>
    <description>The change in Visual Analog Score (Schaumberg D et al Ocular Surface 2009). The global score is calculated from 2 scores, the frequency and severity of dry eye symptoms.
From .</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tear-production</measure>
    <time_frame>4 months</time_frame>
    <description>Schirmers test result</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tear-proteins</measure>
    <time_frame>4 months</time_frame>
    <description>Tear protein analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tear-stability</measure>
    <time_frame>4 months</time_frame>
    <description>Tear break up time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cornea</measure>
    <time_frame>4 months</time_frame>
    <description>other corneal findings such as scarring, vascularisation, filaments etc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conjunctiva</measure>
    <time_frame>4 months</time_frame>
    <description>Documentation of conjunctival hyperemia, chemosis, scarring</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Xerophthalmia</condition>
  <arm_group>
    <arm_group_label>Serum eye drops</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient's autologous serum is diluted in saline solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Autologous serum eyedrops</intervention_name>
    <description>3 times a day for the duration of the study</description>
    <arm_group_label>Serum eye drops</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Seen at the dry eye service at the Singapore National Eye Centre

          -  Age between 21 and 75 years old

          -  Symptomatic for dry eye or VA worse than 6/12 in Snellen chart

          -  Presence of corneal punctate staining involving central zone

          -  Exhausted what is considered as standard therapy or therapy that is acceptable to the
             patient and the physician

          -  No contraindication for blood extraction/plasmapheresis

        Exclusion Criteria:

          -  HIV/HCV/HBV/syphilis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis Tong, FRCS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore National Eye Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ronald Chung</last_name>
    <role>Principal Investigator</role>
    <affiliation>Singapore National Eye Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roger Beuerman</last_name>
    <role>Study Director</role>
    <affiliation>Singapore Eye Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mickey Koh</last_name>
    <role>Study Chair</role>
    <affiliation>Singapore General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samanthila Waduthantri</last_name>
    <role>Study Chair</role>
    <affiliation>Singapore National Eye Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heng Joo Ng</last_name>
    <role>Study Chair</role>
    <affiliation>Singapore General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rohani Salleh</last_name>
    <role>Study Chair</role>
    <affiliation>Singapore General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Singapore National Eye Centre</name>
      <address>
        <city>Singapore</city>
        <zip>168571</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2010</study_first_submitted>
  <study_first_submitted_qc>March 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2010</study_first_posted>
  <last_update_submitted>January 15, 2012</last_update_submitted>
  <last_update_submitted_qc>January 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Singapore National Eye Centre</investigator_affiliation>
    <investigator_full_name>Louis Tong</investigator_full_name>
    <investigator_title>Clinician-Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Xerophthalmia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

